The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: A multicenter, open-labeled, single-arm phase II trial.
 
Junlong Zhuang
No Relationships to Disclose
 
Yuwen Wang
No Relationships to Disclose
 
Shun Zhang
No Relationships to Disclose
 
Xuefeng Qiu
No Relationships to Disclose
 
Feng Zhou
No Relationships to Disclose
 
Yao Fu
No Relationships to Disclose
 
Xuedong Wei
No Relationships to Disclose
 
Linfeng Xu
No Relationships to Disclose
 
Hongqian Guo
No Relationships to Disclose